Medication Assisted Treatment
Medication Assisted Treatment is an evidence-based practice that uses medication and therapy to help relieve substance use withdrawal symptoms as well as cravings that can result in chemical imbalances. Several medications are approved by the Food and Drug Administration (FDA) in the treatment of alcohol and opioid use disorders. MAT is supported and recommended by the United States Surgeon General.
Maryville first began providing MAT services in 2005 with the use of Suboxone for medically monitored withdrawal management (detox). In 2013, Maryville participated in a State of New Jersey pilot program to introduce Vivitrol as an option in residential treatment. Since then, Maryville has extended its MAT services to include its outpatient programs and continues to offer both Suboxone and Vivitrol. Maryville also offers parallel care for individuals on methadone.
At all levels of care, Maryville’s MAT programming combines behavioral therapy with medication to treat alcohol and opioid use disorders. Services may last indefinitely, with ongoing monitoring by a MAT-approved physician or Advanced Practice Nurse (APN).